| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP USD | RVI BIOTECNOLOGÍA | 53,78% | 48,96% | 73,15% | 201,41% |
| JPM US EQUITY ALL CAP C (ACC) EUR (HEDGED) | RVI USA | 13,87% | 58,98% | 45,23% | 201,31% |
| JPM GLOBAL NATURAL RESOURCES C (DIST) EUR | RVI MATERIAS PRIMAS | 58,33% | 60,73% | 93,42% | 201,25% |
| GOLDMAN SACHS MULTI-MANAGER GLOBAL EQUITY PORTFOLIO P DIS USD | RVI GLOBAL | 18,24% | 60,40% | 66,94% | 201,15% |
| M&G (LUX) JAPAN FUND USD C ACC | RVI JAPÓN | 34,29% | 67,74% | 96,68% | 201,14% |
| GAM SUSTAINABLE EMERGING EQUITY ORDINARY EUR CAP | RVI EMERGENTES | 42,86% | 104,39% | 78,48% | 201,12% |
| GOLDMAN SACHS US EQUITY INCOME I CAP EUR | RVI USA VALOR | 10,59% | 44,69% | 75,26% | 201,12% |
| GOLDMAN SACHS US EQUITY INCOME I CAP USD | RVI USA VALOR | 10,02% | 45,70% | 75,26% | 201,12% |
| ROBECO ASIA-PACIFIC EQUITIES F EUR | RVI ASIA PACÍFICO | 49,96% | 88,48% | 96,93% | 200,99% |
| NORDEA 1-NORDIC EQUITY SMALL CAP FUND BC-EUR | RVI PAÍSES NÓRDICOS SMALL/MID CA | 4,40% | 29,99% | 28,52% | 200,88% |
